| Nature of Business | Exporter and Third-Party Manufacturer |
| Additional Business | Exporter
Trader
Manufacture
Supplier
Wholesaler
Distributer |
| Company CEO | Mr. Satish Chander Goyal |
| Industry | |
| Total Number of Employees | |
| Legal Status of Firm | |
| Tan No. | |
| GST No. | |
| CIN No. | |
| Packaging/Payment and Shipment Details |
| Payment Mode | |
| Shipment Mode | |
| Contact Person | |
| Address | 504, dhaka chambers 2068,Block -G Gali No. 38,39 Nai wala ,karol bagh , new delhi 18, Apna Market, Darbra Chowk, Hisar – 125001, Haryana, India |
| City | Delhi |
| State | Delhi |
| Postal Code | 125001 |
| Country | India |
| GST Number | |
| PAN Number | |
| Company Bio | Vision biolife Pvt. Ltd. (formerly known as Vision Remedies ) was established in 2002 as a result of the dedicated efforts put in by a team of committed professionals with strong determination to serve Humanity. We strive to become a knowledge-driven pharmaceutical company with the highest level of operational excellence in all spheres of life. Our core endeavours are to add value to customers and maximise the strength of customer relationships. VISION BIOLIFE is a dynamic & a optimistic player in the pharma industry, having a vision to create a truly international Pharma company that would address complete Pharma needs. The group is managed by the hardcore professionals of the Pharma industry & got the vast experience with unmatched expertise to achieve the strategic goals. VISION BIOLIFE is enjoying a very high reputation among the medical fraternity. VISION BIOLIFE believes in innovation & differentiation, in order to meet our customers need we have developed a huge basket of Pharma products which is addressing all the ... therapeutic dosage forms like Tab, Capsules, syrups, injections, protein powder & herbal products. VISION BIOLIFE is eyeing better health achievement through effective and safe medicines based on technological innovation. Achieving customer satisfaction is fundamental to our business. One of our key objectives has been to develop indigenous processes for new drugs introduced in the developed countries, produce and introduce them in lots of countries |
| Description | |
| Registered At | March 13, 2026 |
